{"id":"W2287692022","doi":"10.1200/jco.2007.25.18_suppl.lba7514","title":"Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"ca_institutions":"Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gemcitabine; Carboplatin; Bevacizumab; Clinical endpoint; Placebo; Oncology; Cisplatin; Chemotherapy; Lung cancer; Progression-free survival; Neutropenia; Surgery; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003599747,0.002665193,0.00481703,0.0007842212,0.0006957892,0.001674614,0.001951145,0.00311513,0.01042651],"category_scores_gemma":[0.002906753,0.001594337,0.001796273,0.0007655188,0.002230398,0.001392931,0.0007709952,0.004406993,0.002424085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001504366,"about_ca_system_score_gemma":0.003334981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001885616,"about_ca_topic_score_gemma":0.004938264,"domain_scores_codex":[0.9986008,0.0008344436,0.00007471915,0.0001877288,0.0001069545,0.0001953648],"domain_scores_gemma":[0.9984683,0.0003074029,0.000296257,0.000126086,0.0001151926,0.0006867219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9743693,0.01507828,0.0003424071,0.0003341834,0.0004338613,0.00003367188,0.00005043125,0.0001965434,0.00300159,0.00008387524,0.0009734097,0.00510246],"study_design_scores_gemma":[0.9593063,0.03963884,0.0004093279,0.000007321225,0.00007805101,0.00001030339,0.000006367577,0.0001081873,0.0001173125,0.0000415692,0.0002701769,0.000006076134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9630586,0.002964253,0.001408656,0.001307835,0.001549795,0.02312544,0.00264064,0.0003111419,0.003633728],"genre_scores_gemma":[0.9543953,0.002862978,0.003623643,0.003109325,0.001006671,0.02383675,0.002868069,0.00007163142,0.008225517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01042651,"threshold_uncertainty_score":0.03488016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03669029450550364,"score_gpt":0.4493433680146531,"score_spread":0.4126530735091495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}